Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Lung cancer classification and identification framework with automatic nodule segmentation screening using machine learning

Lung cancer classification and identification framework with automatic nodule segmentation... Lung cancer is often a fatal disease. To minimize patient mortality, the ability to identify the nodule malignancy stage from computed tomography (CT) lung scans is critical. Most existing methods rely exclusively on deep learning (DL) networks. However, duplicated structures and insufficient training data make DL-based malignancy diagnosis from CT images time-consuming and imprecise. Additionally, the features that DL networks use to make decisions cannot be recognized. In response to these challenges in previous work, we built an end-to-end conventional machine learning (ML) model called ‘NoduleDiag’ to classify cancerous CT images and their malignancy stage based on the nodule characteristics observable in CT images that radiologists typically prefer for diagnosis. We also prepared a fully automatic pulmonary nodule segmentation model for implementation during the final stage of diagnosis (after disease-stage identification) and added it to our classification framework as immense practical assistance to radiologists and medical personnel. To the best of our knowledge, this work will be the first all in one computer-assisted diagnosis (CAD) framework with lung cancer classification, automatic malignancy-stage identification and nodule segmentation screening together using conventional ML approaches. Our proposed model classifies nodule malignancy on a scale of 1–5. It achieves 99.65% accuracy, 99.64% sensitivity, 99.76% precision, 99.9% specificity, and 99.91% negative predictive value (NPV) with XGBoost. Our segmentation model uses DeepLabv3+ (weights initialized by ResNet-18), achieving a 99.86% global accuracy, mean boundary F1 (BF) score of 0.976, 0.715 mean IoU and 0.997 weighted IoU. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Intelligence Springer Journals

Lung cancer classification and identification framework with automatic nodule segmentation screening using machine learning

Applied Intelligence , Volume OnlineFirst – Mar 15, 2023

Loading next page...
 
/lp/springer-journals/lung-cancer-classification-and-identification-framework-with-automatic-y0d0BoulNA
Publisher
Springer Journals
Copyright
Copyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
ISSN
0924-669X
eISSN
1573-7497
DOI
10.1007/s10489-023-04552-1
Publisher site
See Article on Publisher Site

Abstract

Lung cancer is often a fatal disease. To minimize patient mortality, the ability to identify the nodule malignancy stage from computed tomography (CT) lung scans is critical. Most existing methods rely exclusively on deep learning (DL) networks. However, duplicated structures and insufficient training data make DL-based malignancy diagnosis from CT images time-consuming and imprecise. Additionally, the features that DL networks use to make decisions cannot be recognized. In response to these challenges in previous work, we built an end-to-end conventional machine learning (ML) model called ‘NoduleDiag’ to classify cancerous CT images and their malignancy stage based on the nodule characteristics observable in CT images that radiologists typically prefer for diagnosis. We also prepared a fully automatic pulmonary nodule segmentation model for implementation during the final stage of diagnosis (after disease-stage identification) and added it to our classification framework as immense practical assistance to radiologists and medical personnel. To the best of our knowledge, this work will be the first all in one computer-assisted diagnosis (CAD) framework with lung cancer classification, automatic malignancy-stage identification and nodule segmentation screening together using conventional ML approaches. Our proposed model classifies nodule malignancy on a scale of 1–5. It achieves 99.65% accuracy, 99.64% sensitivity, 99.76% precision, 99.9% specificity, and 99.91% negative predictive value (NPV) with XGBoost. Our segmentation model uses DeepLabv3+ (weights initialized by ResNet-18), achieving a 99.86% global accuracy, mean boundary F1 (BF) score of 0.976, 0.715 mean IoU and 0.997 weighted IoU.

Journal

Applied IntelligenceSpringer Journals

Published: Mar 15, 2023

Keywords: Computer-assisted diagnosis; Deep learning; Machine learning; Lung Cancer; Computed tomography; Segmentation

References